New hope for kids fighting cancer and dangerous fungal infections

NCT ID NCT07357038

Summary

This study is watching how well and how safely a medication called L-AmB works to treat serious fungal infections in children and teenagers with blood cancers. These patients are already taking other drugs to prevent such infections, but the infections have broken through. Researchers will observe if the treatment works as well for young patients as it does for adults and if it is safer for their kidneys.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FUNGAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital

    RECRUITING

    Tianjin, Tianjin Municipality, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.